{"product_id":"her-2-making-of-herceptin-0812991842-jjqk","title":"Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer","description":"\u003ch2\u003eWhat Makes Herceptin a Revolutionary Treatment?\u003c\/h2\u003e\u003cp\u003eHerceptin stands as one of the first targeted cancer therapies—medications specifically designed to attack molecular abnormalities within cancer cells. Prior to Herceptin, chemotherapy treated all rapidly dividing cells indiscriminately, often leading to severe side effects. Herceptin, in contrast, zeroes in on the HER2 protein overexpressed in certain breast cancers, providing a much more precise attack. This strategy not only enhanced outcomes for HER2-positive patients but also paved the way for precision oncology. The book lays out this revolution in straightforward language, accessible even to non-scientists.\u003c\/p\u003e\u003ch2\u003eKey Takeaways\u003c\/h2\u003e\u003cp\u003eAfter reading, you'll gain a profound understanding of the intricacies of cancer research and the human narratives behind medical innovations. Central themes include:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eThe Science of HER2:\u003c\/strong\u003e An exploration of how the HER2 gene functions, why its overexpression results in aggressive cancer, and the mechanism by which Herceptin disrupts its signals.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDrug Development Hurdles:\u003c\/strong\u003e The financial, regulatory, and scientific obstacles that almost prevented Herceptin from ever being approved.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThe Power of Patient Advocacy:\u003c\/strong\u003e How relentless advocates fought to accelerate access to the drug, influencing FDA policy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThe Human Element:\u003c\/strong\u003e Personal stories from researchers, clinicians, and patients that convey the emotional significance of clinical trials.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFuture Directions:\u003c\/strong\u003e How the Herceptin story facilitated the development of additional targeted therapies and the growth of personalized medicine.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eWho Should Read This Book?\u003c\/h2\u003e\u003cp\u003e\u003cem\u003eHer-2: The Making of Herceptin\u003c\/em\u003e will captivate a wide range of readers:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHealthcare professionals:\u003c\/strong\u003e Discover the scientific and regulatory path that led to a modern targeted therapy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBreast cancer patients and survivors:\u003c\/strong\u003e Gain perspective on the development of a life-changing treatment and take inspiration from trial participants.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStudents and educators:\u003c\/strong\u003e Use the book as an instructive example of translational medicine, drug development, and advocacy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eScience and medical history buffs:\u003c\/strong\u003e Appreciate a thoroughly researched narrative tracing basic research to clinical practice.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCaregivers and family members:\u003c\/strong\u003e Learn about the disease and treatment choices in an accessible, non-technical style.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eBook Overview\u003c\/h2\u003e\u003cp\u003e\u003cem\u003eHer-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer\u003c\/em\u003e by Robert Bazell offers an enthralling account of one of the most significant advancements in oncology. Herceptin (trastuzumab) is a targeted therapy that zeroes in on cancer cells that overexpress the HER2 protein, dramatically improving the outlook for many women facing aggressive HER2-positive breast cancer. This book takes you behind the scenes of scientific discovery, clinical trials, and the personal stories that shaped this groundbreaking drug. Bazell, an accomplished science journalist, blends molecular biology, corporate dynamics, and human emotion into a narrative that is both informative and touching.\u003c\/p\u003e\u003cp\u003eFrom the research bench to the clinic, the book follows how a serendipitous discovery led to a new paradigm in cancer therapy. It explains the biology of HER2 in plain language and underscores the teamwork of researchers, clinicians, and advocates. More than a drug's story, it is one of hope, determination, and the promise of targeted medicine.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eNote:\u003c\/strong\u003e This book is intended for historical and scientific education and should not replace professional medical advice. Always consult your doctor for health decisions.\u003c\/p\u003e\u003ch2\u003eAbout the Author\u003c\/h2\u003e\u003cp\u003eRobert Bazell is a highly regarded science journalist who covered medical breakthroughs for NBC News and contributed to leading publications. With a background in immunology and extensive experience on the science beat, he excels at transforming intricate scientific concepts into compelling stories. In \u003cem\u003eHer-2: The Making of Herceptin\u003c\/em\u003e, he merges investigative journalism with empathetic storytelling to produce a comprehensive account of a landmark medication.\u003c\/p\u003e\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\u003ch3\u003eIs this book appropriate for someone recently diagnosed with breast cancer?\u003c\/h3\u003e\u003cp\u003eAbsolutely. Despite containing scientific information, the book is aimed at a general audience. Many readers feel empowered by understanding the science behind their treatment. However, it should be treated as background reading, not as medical advice.\u003c\/p\u003e\u003ch3\u003eDoes the book address current treatment options beyond Herceptin?\u003c\/h3\u003e\u003cp\u003eThe primary focus is on the development of Herceptin. Later editions or chapters may discuss subsequent therapies such as Perjeta or Kadcyla, but the core story is centred on Herceptin's history.\u003c\/p\u003e\u003ch3\u003eIs the information still relevant given recent research advances?\u003c\/h3\u003e\u003cp\u003eThe book was originally published in 1998, but the historical and scientific content remains sound. For the most up-to-date treatment recommendations, consult your health-care provider or current medical literature.\u003c\/p\u003e","brand":"Ballantine Books","offers":[{"title":"Default Title","offer_id":48338732122350,"sku":null,"price":60.64,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0816\/1158\/7822\/files\/51TxrJHARML._SL1200_534574e6-a89c-4c57-aaa2-1b25c2028de6.jpg?v=1784306078","url":"https:\/\/vitamin4ca.com\/products\/her-2-making-of-herceptin-0812991842-jjqk","provider":"vitamin4ca","version":"1.0","type":"link"}